title: Complementary PLS and KNN algorithms for improved 3D-QSDAR consensus modeling of AhR binding.
abstract: Multiple validation techniques (Y-scrambling, complete training/test set randomization, determination of the dependence of R2test on the number of randomization cycles, etc.) aimed to improve the reliability of the modeling process were utilized and their effect on the statistical parameters of the models was evaluated. A consensus partial least squares (PLS)-similarity based k-nearest neighbors (KNN) model utilizing 3D-SDAR (three dimensional spectral data-activity relationship) fingerprint descriptors for prediction of the log(1/EC50) values of a dataset of 94 aryl hydrocarbon receptor binders was developed. This consensus model was constructed from a PLS model utilizing 10 ppm x 10 ppm x 0.5 Å bins and 7 latent variables (R2test of 0.617), and a KNN model using 2 ppm x 2 ppm x 0.5 Å bins and 6 neighbors (R2test of 0.622). Compared to individual models, improvement in predictive performance of approximately 10.5% (R2test of 0.685) was observed. Further experiments indicated that this improvement is likely an outcome of the complementarity of the information contained in 3D-SDAR matrices of different granularity. For similarly sized data sets of Aryl hydrocarbon (AhR) binders the consensus KNN and PLS models compare favorably to earlier reports. The ability of 3D-QSDAR (three dimensional quantitative spectral data-activity relationship) to provide structural interpretation was illustrated by a projection of the most frequently occurring bins on the standard coordinate space, thus allowing identification of structural features related to toxicity.
authors.forename: Svetoslav H
authors.initials: SH
authors.lastname: Slavov
authors.forename: Bruce A
authors.initials: BA
authors.lastname: Pearce
authors.forename: Dan A
authors.initials: DA
authors.lastname: Buzatu
authors.forename: Jon G
authors.initials: JG
authors.lastname: Wilkes
authors.affiliation: Division of Systems Biology, National Center for Toxicological Research, US Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079, USA. Richard.Beger@fda.hhs.gov.
authors.forename: Richard D
authors.initials: RD
authors.lastname: Beger